RxDoctor Payments Data

Leticia Peltzer, MD

Otolaryngology · Abingdon, VANPI 1437189149

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. Stryker accounts for 68.3% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $2,366, 8.1 times the $291 reported in 2019. Among otolaryngology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,107in general payments, 2019–2025

Across 112 payments — averaging $72.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$6K
  • Regeneron Healthcare Solutions, Inc.$1K
  • GSK$564
  • Inspire Medical Systems, Inc.$265
  • Optinose US, Inc.$147
  • AstraZeneca$147
  • plus $103 from 6 others

What the payments were for

  • Travel & lodging$3,67845%
  • Food & beverage$4,40854%
  • Education$210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,107 in reported general payments places this provider in the 90th percentile of 241 otolaryngology providers in Virginia.

See all otolaryngology providers in Virginia

Medicare billing

Part B allowed, 2024
$69,697
Medicare patients
195
Services billed
1,573

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab11$39,772
Azelastine Hcl125$3,904
Ofloxacin73$1,891
Naloxone Hcl15$931
Clobetasol Propionate15$858
Ipratropium Bromide32$797
Fluticasone Propionate57$568
Mupirocin63$473
Levocetirizine Dihydrochloride39$388
Ondansetron OdtOndansetron44$343
Cefdinir14$330
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen39$285
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav22$229
Lansoprazole12$226
Levothyroxine Sodium23$149

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Abingdon

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →